Νέα, σημαντικά δεδομένα για την κοινότητα του λεμφώματος

Νέα, σημαντικά δεδομένα για την κοινότητα του λεμφώματος

Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities

As gene therapy gains traction, it is expected to create a number of job opportunities. For example, the UK government projects gene and cell therapy in Britain alone will create 18,000 new jobs by 2030. The U.S. Bureau of Labor Statistics predicts a 7 percent increase in jobs for biomedical engineers and a 13 percent increase in … Συνεχίστε να διαβάζετε Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities.

7 drugmakers to watch on Q3 earnings

7 drugmakers to watch on Q3 earnings

Focused on Off-The-Shelf CAR-T, Allogene Therapeutics Hits the Nasdaq at $18 per Share

Focused on Off-The-Shelf CAR-T, Allogene Therapeutics Hits the Nasdaq at $18 per Share

CAR-T: Τι είναι οι «γενετικές θεραπείες» για λευχαιμία και λέμφωμα

CAR-T: Τι είναι οι «γενετικές θεραπείες» για λευχαιμία και λέμφωμα

Does CAR-T Therapy Have a Payment Problem?

By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying goes, they threw a revolution and nobody came? Or more precisely, what if they threw a revolution and no one was willing to pay for … Συνεχίστε να διαβάζετε Does CAR-T Therapy Have a Payment Problem?.